Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICS: Antibiotic Prophylaxis in Cardiac Surgery
NCT02285140Terminated
- Sponsor
- Hamilton Health Sciences
- Start
- Apr 2015
- Primary completion
- Mar 2025
- Modality
- Reversible Covalent Inhibitors, Cyclic Peptides, Antimicrobial Peptides
- Countries
- 1
01
Overview
Randomised, single-blind trial of vancomycin and cefazolin in surgical site infection (SSI) (4 arms), sponsored by Hamilton Health Sciences. Primary endpoints: Proportion of patients receiving antibiotics according to study protocol at 3 months, Proportion of patients with complete follow-up at 3 months and 1 more. Started Apr 2015; status: terminated.
02
Drugs
vancomycincefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02285140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02285140.